Treatment of mild persistent asthma
نویسندگان
چکیده
منابع مشابه
Treatment of mild persistent asthma in children.
Fernando Martinez and co-workers (Feb 19, p 650) highlight that daily use of inhaled corticosteroids is associated with reduced growth, and that intermittent use of these drugs to control mild persistent asthma avoids such growth impairment. This statement could lead physicians and (parents of) patients to think that daily inhaled corticosteroid treatment is unsafe and stunts growth. I would li...
متن کاملTreatment of mild persistent asthma by cutaneous electronic stimulation.
The Global Initiative for Asthma (GINA) has emphasised the importance of assessing control in response to treatment in grading asthma severity [1]. However, many asthma patients are inadequately controlled despite conventional treatment. GINA also recognises a potential role for complementary medicine in asthma management [1]. Fenzian (Eumedic Ltd, Hungerford, UK) is a device that provides low ...
متن کاملEvaluation of Omeprazole in the Treatment of Moderate to Severe Persistent Asthma in Children
Background and Objective: Asthma is the most common chronic disease of childhood. The disease is caused by a temporary blockage of airflow due to chronic inflammation of the airways . One of the conditions that often occur with asthma and exacerbate disease, is gastroesophageal reflux. The aim of this study is to evaluate the role of acid suppressing therapy in patients with refractory asthma...
متن کاملAirway inflammation in mild intermittent and in persistent asthma.
The severity of asthma can be graded from mild intermittent to severe persistent. Airway inflammation is a feature of persistent asthma. We compared several markers of inflammation in mucosal biopsies and bronchoalveolar lavage fluid (BAL fluid) from 12 healthy control subjects, 24 patients with intermittent asthma, and 18 patients with mild-to-moderate persistent asthma. Epithelial shedding, e...
متن کاملMontelukast as monotherapy in children with mild persistent asthma.
The cysteinyl leukotrienes cause bronchoconstriction, increased mucus production and airway inflammation, three major features of asthma. Several randomized controlled trials have shown the efficacy of leukotriene receptor antagonists for improving asthma outcomes. The drug is favored for treating childhood asthma, where poor compliance with inhalation therapy is a therapeutic challenge. To ass...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Primary Care Respiratory Journal
سال: 2008
ISSN: 1471-4418,1475-1534
DOI: 10.3132/pcrj.2008.00006